glp-1 therapy gonzales Oral Solution – Affordable Weight Loss Treatment For Overweight Adults The GLP-1 Advantage Beyond the

In fact, as well detail in a later section, liraglutide in 2016 became the first GLP-1 agonist shown to reduce cardiovascular events in a dedicated outcomes trial (LEADER) an immensely important finding that added another dimension to its therapeutic profile

FDA Disclaimer These statements have not been evaluated by the Food and Drug Administration

Reported side effects are typically mild and may include: Mild nausea (usually with oral forms) Temporary dizziness Gastrointestinal discomfort Injection site reactions (with injectable form) Most users report no significant side effects, making it an attractive option for those concerned about adverse reactions to traditional medications

When the medication is stopped, these effects cease and appetite increases again